Article
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.
Metabolism: clinical and experimental - 1 Sept 2001
Juneja R, Hirsch I B, Naik R G, Brooks-Worrell B M, Greenbaum C J, Palmer J P
Abstract excerpt
This study was undertaken to determine which type 1 diabetes-associated autoantibodies and what clinical characteristics are most useful to identify patients with type 1(1/2) diabetes. We studied 125 patients, recently diagnosed clinically with type 2 diabetes for the presence of islet cell antibodies (ICA), insulin autoantibodies (IAA), antibodies to glutamic acid decarboxylase(GADAb), and IA-2a (IA-2Ab)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
